Eilean Therapeutics
PrivateLast Round
Seed
Jul 30, 2020
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Eilean Therapeutics is a biopharmaceutical company that develops small molecule therapies targeting resistance mechanisms in hematologic and solid cancers.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Clinical Trials, Precision Medicine, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eilean Therapeutics Comparables
Compare Eilean Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kurome Therapeutics | 93% | |
| Aptose Biosciences Inc. | 79% | |
| Curis Inc | 77% | |
Eilean Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 30, 2020 |
Eilean Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Seed |
| Torrey Pines Investment LLC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 42% MoM.
- Dec 15, 2024
Monthly visitors increased 161% MoM, reaching 1.5K.
Eilean Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eilean Therapeutics's valuation, stock price, and market status.